XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Cash flows from operating activities:    
Net income (loss) $ 180,809 $ (104,042)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 51,223 53,388
Non-cash lease expense 95,097 97,655
Benefit for deferred income taxes (1,275) (17,074)
Share-based compensation expense 11,968 11,257
Store impairment   14,528
Loss on disposition of property and equipment, net 121 679
Changes in assets and liabilities:    
Receivables (4,349) 27,912
Inventory (93,049) 58,002
Prepaid expenses and other assets 4,272 (62,170)
Payables, accrued expenses and other liabilities 61,586 94,196
Operating lease liabilities (111,210) (59,115)
Net cash provided by operating activities 195,193 115,216
Cash flows from investing activities:    
Cash paid for property and equipment (105,624) (72,103)
Cash paid for marketable securities (165,927) (92,949)
Sales and maturities of marketable securities 148,582 383,056
Net cash (used in) provided by investing activities (122,969) 218,004
Cash flows from financing activities:    
Borrowings under debt   220,000
Repayments of debt   (100,000)
Proceeds from the exercise of stock options 2,815  
Share repurchases related to share repurchase program   (7,036)
Share repurchases related to taxes for share-based awards (7,562) (3,742)
Net cash (used in) provided by financing activities (4,747) 109,222
Effect of exchange rate changes on cash and cash equivalents 1,699 (1,421)
Increase in cash and cash equivalents 69,176 441,021
Cash and cash equivalents at beginning of period 395,635 221,839
Cash and cash equivalents at end of period 464,811 662,860
Cash paid during the year for:    
Income taxes 42,767 11,287
Non-cash investing activities—Accrued capital expenditures $ 60,168 $ 2,710